In game theory, outcomes depend on the nature of the game and the payoffs. Healthcare is a game of incomplete...
Read moreThe CDC must decide whether to proceed with a new generation of vaccines that promise longer immunity. But many unknowns...
Read moreGlobally, 1.15% of tweets related to COVID-19 vaccines mentioned side effects. Sentiments toward vaccines were on average more negative than...
Read moreDonald Trump is contagious. He infects susceptible patients with a flair for dramatic individualism. And it seems Trumpism will affect...
Read moreOvarian cancer is the most deadly of gynecologic tumors. Fewer than 40% of those diagnosed with ovarian cancer are cured,...
Read moreBefore the COVID-19 pandemic, most people didn’t think through some basic decisions in the same way they might now. In...
Read moreThere have been several cases of doctors expressing skepticism about vaccines in the media.
Read moreCoughs are everywhere this time of the year. They appear to be both harmless yet persistent, which make coughs particularly...
Read moreClinical trials represent the science in healthcare. It is how we obtain new medical information. But to advance our knowledge...
Read moreThis ability to minimize or exaggerate a situation by simply adding a suffix is one feature of the Spanish language...
Read moreThe fact that the communities with the worst health outcomes are also the communities least likely to be meaningfully engaged...
Read moreAutonomy is one of the pillars of bioethics, and it is the notion that the patient has the ultimate decision-making...
Read moreCan lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy